New formulations should aim to produce antibody responses to the XBB.1.5 or XBB.1.16 variants, the advisory group said, adding that other formulations or platforms that achieve neutralizing antibody responses against XBB lineages could also be considered
from Top World News- News18.com https://ift.tt/XH5ZxMF
https://ift.tt/nsPflHi
from Top World News- News18.com https://ift.tt/XH5ZxMF
https://ift.tt/nsPflHi